Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial
{{output}}
External comparator (EC) studies can improve identification of compounds with the most promising performance in pre-pivotal single-arm trials (SAT). As SAT output lacks comparative insights, EC studies allow efficient contextualization of compound performance ... ...
